Association between the use of selective serotonin reuptake inhibitors and multiple sclerosis disability progression

Subscribe to email list

Please select the email list(s) to which you wish to subscribe.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA

Enter the characters shown in the image.

User menu

You are here

  1. Department of Statistics
  2. Association between the use of selective serotonin reuptake inhibitors and multiple sclerosis disability progression

Association between the use of selective serotonin reuptake inhibitors and multiple sclerosis disability progression

TitleAssociation between the use of selective serotonin reuptake inhibitors and multiple sclerosis disability progression
Publication TypeJournal Article
Year of Publication2016
AuthorsZhang, T, Kingwell, E, De Jong, HJI, Zhu, F, Zhao, Y, Carruthers, R, Petkau, J, Gustafson, P, Oger, J, Tremlett, H
JournalPharmacoepidemiology and Drug Safety
DOI10.1002/pds.4031